Active Constituent: PIMOBENDAN

The New Addition to the Jurox Cardiology Range

Available in
1.25 mg, 2.5 mg and 5 mg in bottles of 84 tablets.

*Riviere J.E and Papich M.G Veterinary Pharmacology and Therapeutics Ninth Edition 2009 Iowa, Blackwell Publishing

What is CorMedin®?

CorMedin is a pimobendan product available in 1.25 mg, 2.5 mg and 5 mg sizes. CorMedin can be used to treat canine congestive heart failure (CHF) originating from dilated cardiomyopathy (DCM) or valvular insufficiency (mitral and / or tricuspid regurgitation).

How does it work?

Pimobendan has a dual action mechanism. It exhibits positive inotropic effects through sensitisation of the cardiac muscle to calcium, allowing cardiac contractions to be more efficient without utilising additional oxygen. Pimobendan also inhibits the action of phosphodiesterase (type III) in vascular smooth muscle, resulting in vasodilation, helping to reduce workload on the heart.

Offer Your Clients the Best Tools for Compliance

Send your client home with and help them stay on top of their medication with the Heart Health Kit & Heart Health for Dogs App

Active Constituent: PIMOBENDAN

Available in
1.25 mg, 2.5 mg and 5 mg in bottles of 84 tablets.

CorMedin can be used to treat canine congestive heart failure (CHF) originating from dilated cardiomyopathy (DCM) or valvular insufficiency (mitral and / or tricuspid regurgitation).
Active Constituent: Furosemide 40 mg

Available in
100 and 1000 tablet bottles.

Furosemide is an efficient diuretic which increases the urinary excretion of water, sodium, chloride and potassium. It acts primarily by affecting sodium resorption in the loop of Henle. Diuretic effects may occur within one hour after oral dosing, and peak effects within two hours.
Active Constituent: Benazepril hydrochloride 2.5 mg, 5 mg, 20 mg tablets.

Available in
28 and 42 tablet packs: 2.5 mg, 5 mg and 20 mg

VetACE is an angiotensin converting enzyme (ACE) inhibitor, and works by decreasing pressure on the heart by reducing fluid retention and limiting blood vessel constriction.

Talk to a Territory Manager